{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:48:58Z","timestamp":1769600938372,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme for research, technological development and demonstration","award":["601040"],"award-info":[{"award-number":["601040"]}]},{"DOI":"10.13039\/501100007192","name":"Rijksinstituut voor Volksgezondheid en Milieu","doi-asserted-by":"crossref","award":["9051 4524"],"award-info":[{"award-number":["9051 4524"]}],"id":[{"id":"10.13039\/501100007192","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-1019-6","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T08:56:28Z","timestamp":1533286588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-1279","authenticated-orcid":false,"given":"Suzan","family":"Vreemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C. M.","family":"van Zelst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margrethe","family":"Schlooz-Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bult","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Karssemeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Gubern-M\u00e9rida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritse M.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"1019_CR1","doi-asserted-by":"crossref","unstructured":"Nystrom L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmo, Stockholm, and Goteborg. J Med Screen. 2017;24(1):34-42.","DOI":"10.1177\/0969141316648987"},{"issue":"3","key":"1019_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676\u201389.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1019_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/A:1006480106487","volume":"63","author":"MM Tilanus-Linthorst","year":"2000","unstructured":"Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat. 2000;63(1):53\u201360.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1019_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351(5):427\u201337.","journal-title":"N Engl J Med"},{"issue":"10","key":"1019_CR5","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/cncr.20221","volume":"100","author":"IK Komenaka","year":"2004","unstructured":"Komenaka IK, Ditkoff BA, Joseph KA, Russo D, Gorroochurn P, Ward M, Horowitz E, El-Tamer MB, Schnabel FR. The development of interval breast malignancies in patients with BRCA mutations. Cancer. 2004;100(10):2079\u201383.","journal-title":"Cancer"},{"issue":"7","key":"1019_CR6","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"RM Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K, Boetes C, Breast MRI. Guidelines from the European Society of Breast Imaging. Eur Radiol. 2008;18(7):1307\u201318.","journal-title":"Eur Radiol"},{"issue":"2","key":"1019_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75\u201389.","journal-title":"CA Cancer J Clin"},{"issue":"9473","key":"1019_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365(9473):1769\u201378.","journal-title":"Lancet"},{"issue":"36","key":"1019_CR9","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","volume":"28","author":"AJ Rijnsburger","year":"2010","unstructured":"Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol. 2010;28(36):5265\u201373.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1019_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","volume":"28","author":"C Kuhl","year":"2010","unstructured":"Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010;28(9):1450\u20137.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1019_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292(11):1317\u201325.","journal-title":"JAMA"},{"issue":"10","key":"1019_CR12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","volume":"33","author":"CC Riedl","year":"2015","unstructured":"Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK, Rudas M, Singer CF, Helbich TH. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol. 2015;33(10):1128\u201335.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1019_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10549-014-2888-8","volume":"144","author":"IM Obdeijn","year":"2014","unstructured":"Obdeijn IM, Winter-Warnars GA, Mann RM, Hooning MJ, Hunink MG, Tilanus-Linthorst MM. Should we screen BRCA1 mutation carriers only with MRI? A multicenter study. Breast Cancer Res Treat. 2014;144(3):577\u201382.","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"1019_CR14","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","volume":"295","author":"SK Plevritis","year":"2006","unstructured":"Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM. Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295(20):2374\u201384.","journal-title":"JAMA"},{"issue":"1","key":"1019_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1148\/radiol.2461062173","volume":"246","author":"S Schrading","year":"2008","unstructured":"Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology. 2008;246(1):58\u201370.","journal-title":"Radiology"},{"issue":"1","key":"1019_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ijc.10666","volume":"102","author":"M Tilanus-Linthorst","year":"2002","unstructured":"Tilanus-Linthorst M, Verhoog L, Obdeijn IM, Bartels K, Menke-Pluymers M, Eggermont A, Klijn J, Meijers-Heijboer H, van der Kwast T, Brekelmans C. A BRCA1\/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer. 2002;102(1):91\u20135.","journal-title":"Int J Cancer"},{"issue":"3","key":"1019_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/djn440","volume":"101","author":"A Berrington de Gonzalez","year":"2009","unstructured":"Berrington de Gonzalez A, Berg CD, Visvanathan K, Robson M. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst. 2009;101(3):205\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"1019_CR18","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1200\/JCO.2005.03.3126","volume":"24","author":"N Andrieu","year":"2006","unstructured":"Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1\/2 mutation carriers in the international BRCA1\/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators\u2019 Group. J Clin Oncol. 2006;24(21):3361\u20136.","journal-title":"J Clin Oncol"},{"key":"1019_CR19","volume-title":"Breast Cancer Guideline","author":"NABON","year":"2012","unstructured":"NABON: Breast Cancer Guideline. 2012."},{"key":"1019_CR20","doi-asserted-by":"crossref","unstructured":"Vreemann S, Gubern-Merida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, Karssemeijer N, Mann RM. Influence of risk category and screening round on the performance of an MR imaging and mammography screening program in carriers of the BRCA mutation and other women at increased risk. Radiology. 2018;286(2):443-51.","DOI":"10.1148\/radiol.2017170458"},{"key":"1019_CR21","doi-asserted-by":"crossref","unstructured":"Dalmis MU, Litjens G, Holland K, Setio A, Mann R, Karssemeijer N, Gubern-Merida A. Using deep learning to Segment breast and fibroglanduar tissue in MRI volumes. Med Phys. 2017;44(2):533-46.","DOI":"10.1002\/mp.12079"},{"issue":"3","key":"1019_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.mric.2013.02.005","volume":"21","author":"SD Edwards","year":"2013","unstructured":"Edwards SD, Lipson JA, Ikeda DM, Lee JM. Updates and revisions to the BI-RADS magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am. 2013;21(3):483\u201393.","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"2","key":"1019_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.mric.2010.02.001","volume":"18","author":"V Molleran","year":"2010","unstructured":"Molleran V, Mahoney MC. The BI-RADS breast magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am. 2010;18(2):171\u201385. vii","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"7","key":"1019_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1200\/JCO.2007.12.6078","volume":"26","author":"KA Metcalfe","year":"2008","unstructured":"Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol. 2008;26(7):1093\u20137.","journal-title":"J Clin Oncol"},{"key":"1019_CR25","doi-asserted-by":"crossref","unstructured":"van Zelst JCM, Mus RDM, Woldringh G, Rutten M, Bult P, Vreemann S, de Jong M, Karssemeijer N, Hoogerbrugge N, Mann RM. Surveillance of women with the BRCA1 or BRCA2 mutation by using biannual automated breast US, MR imaging, and mammography. Radiology. 2017;285(2):376-88.","DOI":"10.1148\/radiol.2017161218"},{"issue":"2","key":"1019_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/RLI.0b013e3181f3fcdf","volume":"46","author":"F Sardanelli","year":"2011","unstructured":"Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S, et al. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): final results. Investig Radiol. 2011;46(2):94\u2013105.","journal-title":"Investig Radiol"},{"issue":"3","key":"1019_CR27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1148\/radiol.2016151419","volume":"280","author":"JS Sung","year":"2016","unstructured":"Sung JS, Stamler S, Brooks J, Kaplan J, Huang T, Dershaw DD, Lee CH, Morris EA, Comstock CE. Breast cancers detected at screening MR imaging and mammography in patients at high risk: method of detection reflects tumor histopathologic results. Radiology. 2016;280(3):716\u201322.","journal-title":"Radiology"},{"issue":"13","key":"1019_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2007.06.007","volume":"43","author":"SJ Lord","year":"2007","unstructured":"Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905\u201317.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1019_CR29","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-11-1196","volume":"21","author":"EA Heijnsdijk","year":"2012","unstructured":"Heijnsdijk EA, Warner E, Gilbert FJ, Tilanus-Linthorst MM, Evans G, Causer PA, Eeles RA, Kaas R, Draisma G, Ramsay EA, et al. Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomark Prev. 2012;21(9):1458\u201368.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"1019_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10549-016-3912-y","volume":"158","author":"AK Narayan","year":"2016","unstructured":"Narayan AK, Visvanathan K, Harvey SC. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study. Breast Cancer Res Treat. 2016;158(3):583\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"1019_CR31","doi-asserted-by":"crossref","unstructured":"Vreemann S, Gubern-Merida A, Lardenoije S, Bult P, Karssemeijer N, Pinker K, Mann RM. The frequency of missed breast cancers in women participating in a high-risk MRI screening program. Breast Cancer Res Treat. 2018;169(2):323-31.","DOI":"10.1007\/s10549-018-4688-z"},{"issue":"2","key":"1019_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejrad.2015.11.031","volume":"85","author":"A Gubern-Merida","year":"2016","unstructured":"Gubern-Merida A, Vreemann S, Marti R, Melendez J, Lardenoije S, Mann RM, Karssemeijer N, Platel B. Automated detection of breast cancer in false-negative screening MRI studies from women at increased risk. Eur J Radiol. 2016;85(2):472\u20139.","journal-title":"Eur J Radiol"},{"issue":"6","key":"1019_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/bjc.2016.32","volume":"114","author":"XA Phi","year":"2016","unstructured":"Phi XA, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Hooning MJ, Mandel R, et al. Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer. 2016;114(6):631\u20137.","journal-title":"Br J Cancer"},{"issue":"13","key":"1019_CR34","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jama.2012.388","volume":"307","author":"WA Berg","year":"2012","unstructured":"Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, Bohm-Velez M, Mahoney MC, Evans WP 3rd, Larsen LH, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394\u2013404.","journal-title":"JAMA"},{"issue":"1","key":"1019_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00330-015-3803-3","volume":"26","author":"K Lang","year":"2016","unstructured":"Lang K, Andersson I, Rosso A, Tingberg A, Timberg P, Zackrisson S. Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmo Breast Tomosynthesis Screening Trial, a population-based study. Eur Radiol. 2016;26(1):184\u201390.","journal-title":"Eur Radiol"},{"issue":"1040","key":"1019_CR36","doi-asserted-by":"publisher","first-page":"20140080","DOI":"10.1259\/bjr.20140080","volume":"87","author":"K Lang","year":"2014","unstructured":"Lang K, Andersson I, Zackrisson S. Breast cancer detection in digital breast tomosynthesis and digital mammography-a side-by-side review of discrepant cases. Br J Radiol. 2014;87(1040):20140080.","journal-title":"Br J Radiol"},{"key":"1019_CR37","doi-asserted-by":"crossref","unstructured":"Kuhl CK. Abbreviated breast MRI for screening women with dense breast: the EA1141 trial. Br J Radiol. 2017:20170441. [Epub ahead of print].","DOI":"10.1259\/bjr.20170441"},{"issue":"2","key":"1019_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.breast.2014.12.002","volume":"24","author":"TM Svahn","year":"2015","unstructured":"Svahn TM, Houssami N, Sechopoulos I, Mattsson S. Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view full-field digital mammography. Breast. 2015;24(2):93\u20139.","journal-title":"Breast"},{"issue":"12","key":"1019_CR39","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ejrad.2016.10.004","volume":"85","author":"P Clauser","year":"2016","unstructured":"Clauser P, Nagl G, Helbich TH, Pinker-Domenig K, Weber M, Kapetas P, Bernathova M, Baltzer PAT. Diagnostic performance of digital breast tomosynthesis with a wide scan angle compared to full-field digital mammography for the detection and characterization of microcalcifications. Eur J Radiol. 2016;85(12):2161\u20138.","journal-title":"Eur J Radiol"},{"issue":"21","key":"1019_CR40","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998\u20132005.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1019_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1258\/jms.2012.012082","volume":"19","author":"D Puliti","year":"2012","unstructured":"Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19(Suppl 1):42\u201356.","journal-title":"J Med Screen"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-1019-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T19:11:01Z","timestamp":1564773061000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-1019-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-1019-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"11 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by our local institutional review board (CMO Arnhem-Nijmegen) and the requirement for informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"84"}}